Concurrently, locomotor function and coordination declined at 8 weeks in both untreated and ALLO-treated Npc1−/− mice, but the rate of decline was lower in ALLO-treated NPC mice. The gene discussed is NPC1; the disease is nasopharyngeal carcinoma.